Clinical trial
An Extension, Observational Protocol to Evaluate the Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C in the Original Study ML17862
NCT00361179 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Extension, Observational Protocol to Evaluate the Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C in the Original Study ML17862
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- December 31, 2011
- Enrollment
- 320
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coinfection with hepatitis b virus and hepatitis c virus, monoinfection with hepatitis c virus